GALECTIN THERAPEUTICS INC's ticker is and the CUSIP is 363225952. A total of 3 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19 | +35.7% | 9,900 | 0.0% | 0.00% | – |
| Q2 2023 | $14 | -36.4% | 9,900 | -7.5% | 0.00% | – |
| Q1 2023 | $22 | -60.7% | 10,700 | -78.6% | 0.00% | – |
| Q4 2022 | $56 | -99.9% | 50,000 | +54.3% | 0.00% | – |
| Q3 2022 | $52,000 | -17.5% | 32,400 | -33.5% | 0.00% | – |
| Q2 2022 | $63,000 | +133.3% | 48,700 | +188.2% | 0.00% | – |
| Q1 2022 | $27,000 | +125.0% | 16,900 | +186.4% | 0.00% | – |
| Q4 2021 | $12,000 | -84.0% | 5,900 | -74.5% | 0.00% | – |
| Q3 2021 | $75,000 | +2.7% | 23,100 | 0.0% | 0.00% | – |
| Q2 2021 | $73,000 | +82.5% | 23,100 | +12386.5% | 0.00% | – |
| Q1 2021 | $40,000 | -35.5% | 185 | -33.2% | 0.00% | – |
| Q4 2020 | $62,000 | +24.0% | 277 | +45.8% | 0.00% | – |
| Q3 2020 | $50,000 | +47.1% | 190 | +68.1% | 0.00% | – |
| Q2 2020 | $34,000 | +47.8% | 113 | -4.2% | 0.00% | – |
| Q1 2020 | $23,000 | -39.5% | 118 | -11.9% | 0.00% | – |
| Q4 2019 | $38,000 | +2.7% | 134 | +32.7% | 0.00% | – |
| Q3 2019 | $37,000 | -31.5% | 101 | -23.5% | 0.00% | – |
| Q2 2019 | $54,000 | +54.3% | 132 | +88.6% | 0.00% | – |
| Q1 2019 | $35,000 | -55.1% | 70 | -69.6% | 0.00% | – |
| Q4 2018 | $78,000 | -47.7% | 230 | -7.6% | 0.00% | – |
| Q3 2018 | $149,000 | +86.2% | 249 | +97.6% | 0.00% | – |
| Q2 2018 | $80,000 | +1233.3% | 126 | +10.5% | 0.00% | – |
| Q1 2018 | $6,000 | – | 114 | +40.7% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 81 | 0.0% | 0.00% | – |
| Q3 2017 | $6,000 | -25.0% | 81 | -13.8% | 0.00% | – |
| Q2 2017 | $8,000 | +166.7% | 94 | +308.7% | 0.00% | – |
| Q1 2017 | $3,000 | -57.1% | 23 | -56.6% | 0.00% | – |
| Q3 2016 | $7,000 | 0.0% | 53 | +307.7% | 0.00% | – |
| Q2 2016 | $7,000 | -53.3% | 13 | -48.0% | 0.00% | -100.0% |
| Q1 2016 | $15,000 | -83.1% | 25 | -74.2% | 0.00% | -90.9% |
| Q4 2014 | $89,000 | – | 97 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 14,100 | $71,000 | 0.00% |